30 March 2009
Treatment of migraine attacks by compression of temporal superficial arteries using a device
Carlo CianchettiABCDEFG, Maria Elisabetta CianchettiBCF, Tiziana PisanoBCF, Yousef HmaidanBCFMed Sci Monit 2009; 15(4): CR185-188 :: ID: 869619
Abstract
Background
We recently reported that prolonged compression of the scalp arteries blocks pain in a large percentage of migraine attacks. We aimed to determine whether the use of a simple device that compresses the temporal superficial arteries can ameliorate migraine pain.
Material and Method
Thirty consecutive patients (21 women, 9 men), who had positive effect with prolonged digital compression, were included in this study. Subjects were instructed to apply a simple device that firmly compresses both temporal arteries at the onset of each migraine attack.
Results
Eight subjects terminated treatment because of localized pain induced by compression of the device. In the remaining 22 subjects, 38.4% of all attacks in the first treatment month and 52.5% in the second month were aborted or attenuated by at least 1 degree of severity. Painkiller use dropped from a mean of 6.9 tablets in the month prior to use of the device to a mean of 4.5 in the first month and 3.8 in the second month of application of the device; the differences were statistically significant for both months (p<.001). Opinions regarding the effect of the device were positive for 15 subjects (slightly for 3, moderately for 8, and markedly for 4) and negative for 3; the remaining 4 subjects were uncertain as to its effect.
Conclusions
A simple device that induces compression of the temporal arteries can abort or reduce pain in a significant number of migraine attacks. This represents a new method for treating migraine attacks and suggests the involvement of extracranial nociceptive afferents in the pathophysiology of migraine.
Keywords: Migraine Disorders - therapy, Equipment and Supplies, Adolescent, Temporal Arteries - physiopathology, young adult
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952